Inactive Instrument

Varian Medical Systems, Inc.

Equities

VAR

US92220P1057

ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - AMAG, SBPH, VAR, SINA, GARS

October 05, 2020 at 11:09 pm EDT

NEW YORK, Oct. 5, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating:

(PRNewsfoto/Halper Sadeh LLP)

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Covis Group S.à r.l. for $13.75 per share in cash. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/amag-pharmaceuticals-inc-stock-merger-covis/.

Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its proposed merger with F-star Therapeutics, Limited. Under the terms of the share exchange agreement, Spring Bank will acquire all of the outstanding share capital of F-star in exchange for the issuance of newly issued shares of Spring Bank common stock. Spring Bank shareholders will own approximately 38.8% of the combined company. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/spring-bank-pharmaceuticals-inc-sbph-stock-merger-fstar/.

Varian Medical Systems, Inc. (NYSE: VAR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Siemens Healthineers AG for $177.50 per share. Visit our website to learn more and participate in an action: https://halpersadeh.com/actions/varian-medical-systems-inc-var-stock-merger-siemens.

SINA Corporation (NASDAQ: SINA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to New Wave Holdings Limited and New Wave Mergersub Limited for $43.30 in cash per share. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/sina-corporation-stock-merger-new-wave/.

Garrison Capital Inc. (NASDAQ: GARS) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Portman Ridge Finance Corporation. Following the proposed transaction, Garrison Capital shareholders are expected to own approximately 41.6% of the combined company. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/garrison-capital-inc-gars-portman-ridge-stock-merger/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/alert-halper-sadeh-llp-continues-to-investigate-the-following-mergers-shareholders-are-encouraged-to-contact-the-firm---amag-sbph-var-sina-gars-301146134.html

SOURCE Halper Sadeh LLP

Latest news about Varian Medical Systems, Inc.

Varian and Nova Scotia Health Form First Multi-Disciplinary Oncology Partnership to Catalyze Advancements in Cancer Care	Jan. 04	CI
Varian Medical Systems, Inc. acquired Aspekt Solutions.	23-09-25	CI
Varian Announces First Participant Treated in RADIATE-VT Clinical Trial of Cardiac Radioablation for Patients with Refractory Ventricular Tachycardia	23-05-19	CI
Varian Collaborating with Nova Scotia Health to Transform Cancer Care	23-02-17	CI
Varian Receives Investigational Device Exemption for Flash Technology Clinical Trial, FAST-02	22-06-27	CI
Adaptiiv Collaborates with HP and Varian to Enhance Personalization in Radiation Oncology with 3D Printed Medical Devices	22-05-06	CI
Oulu University Hospital in Finland Enters Long-Term Strategic Partnership with Varian and Siemens Healthineers	22-01-19	CI
Varian and Icon Oncology Partner to Establish Value-Based Cancer Treatment Hub for Southern Africa	21-12-14	CI
Varian and the Cincinnati Children's/UC Health Proton Therapy Center Complete Enrollment of FAST-01, First Human Clinical Trial of FLASH Therapy for Cancer	21-10-25	CI
Varian Medical Systems, Inc. Receives FDA "Breakthrough Device Designation" For Embozene® Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis	21-10-13	CI
Elekta : Medical equipment maker Elekta sees higher supply chain costs, shares fall	21-08-25	RE
Icon Group First in World to Adopt New Multi-Disciplinary Oncology Information System from Varian	21-08-05	CI
Siemens : Targets Higher Full-Year Profit As Demand Surge Beats Supply Chain Woes	21-08-05	MT
Siemens Backs Fiscal Year 2021 Outlook, Including Varian Deal	21-06-24	DJ
Varian Receives FDA "Breakthrough Device Designation" for its Cardiac Radioablation System for Treatment of Refractory Ventricular Tachycardia (VT)	21-05-26	CI
Siemens : Raises FY21 Outlook As Fiscal H1 Profit Doubles	21-05-07	MT
Siemens Healthineers : Strong COVID-19 Antigen Test Sales Prompt Siemens Healthineers Full-Year Guidance Boost	21-05-03	MT
Varian Medical Systems, Inc.(NYSE:VAR) dropped from S&P 500 EQUAL WEIGHTED	21-04-20	CI
Varian Medical Systems, Inc.(NYSE:VAR) dropped from S&P TMI Index	21-04-20	CI
Varian Medical Systems, Inc.(NYSE:VAR) dropped from S&P Global BMI Index	21-04-20	CI
Varian Medical Systems, Inc.(NYSE:VAR) dropped from S&P 500	21-04-20	CI
Varian Medical Systems, Inc.(NYSE:VAR) dropped from S&P 500 Growth	21-04-20	CI
Varian Medical Systems, Inc.(NYSE:VAR) dropped from S&P Global 1200	21-04-20	CI
Varian Medical Systems, Inc.(NYSE:VAR) dropped from S&P 500 Health Care Equipment & Services (Industry Group)	21-04-20	CI
Varian Medical Systems, Inc.(NYSE:VAR) dropped from S&P 500 Health Care	21-04-20	CI

Chart Varian Medical Systems, Inc.

Duration

Period

More charts

Company Profile

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, cardiac radioablation, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product. Through its subsidiary, Cooperative CL Enterprises, the Company distributes radiotherapy equipments in Taiwan.

Sector

More about the company